The possible repositioning of an oral anti-arthritic drug, auranofin, for Nrf2-activating therapy: The demonstration of Nrf2-dependent anti-oxidative action using a zebrafish model

The possible repositioning of an oral anti-arthritic drug, auranofin, for Nrf2-activating therapy: The demonstration of Nrf2-dependent anti-oxidative action using a zebrafish model

Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Free Radical Biology and Medicine - Volume 115, 1 February 2018, Pages 405-411

Yuji Fuse, Yuka Endo, Sho Araoi, Hiroaki Daitoku, Hiroyuki Suzuki, Mitsuyasu Kato, Makoto Kobayashi,